224 related articles for article (PubMed ID: 33086849)
1. Therapy of uveal melanoma A Review.
Rusňák Š; Hecová L; Kasl Z; Sobotová M; Hauer L
Cesk Slov Oftalmol; 2020; 77(1):1-13. PubMed ID: 33086849
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
3. Uveal melanomas. Conservation treatment.
Munzenrider JE
Hematol Oncol Clin North Am; 2001 Apr; 15(2):389-402. PubMed ID: 11370500
[TBL] [Abstract][Full Text] [Related]
4. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement.
Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
Arch Ophthalmol; 1999 Feb; 117(2):170-7. PubMed ID: 10037560
[TBL] [Abstract][Full Text] [Related]
5. Uveal melanoma: relatively rare but deadly cancer.
Kaliki S; Shields CL
Eye (Lond); 2017 Feb; 31(2):241-257. PubMed ID: 27911450
[TBL] [Abstract][Full Text] [Related]
6. Deterioration of Visual Acuity after Brachytherapy and Proton Therapy of Uveal Melanoma, and Methods of Counteracting This Complication Based on Recent Publications.
Jarczak J; Karska-Basta I; Romanowska-Dixon B
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374335
[TBL] [Abstract][Full Text] [Related]
7. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.
Shields CL; Naseripour M; Cater J; Shields JA; Demirci H; Youseff A; Freire J
Ophthalmology; 2002 Oct; 109(10):1838-49. PubMed ID: 12359604
[TBL] [Abstract][Full Text] [Related]
8. Comparison of iodine-125 plaque brachytherapy and gamma knife stereotactic radiosurgery treatment outcomes for uveal melanoma patients.
Guleser UY; Sarici AM; Ucar D; Gonen B; Sengul Samanci N; Özgüroğlu M
Graefes Arch Clin Exp Ophthalmol; 2022 Apr; 260(4):1337-1343. PubMed ID: 34735632
[TBL] [Abstract][Full Text] [Related]
9. Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.
Kim EA; Salazar D; McCannel CA; Kamrava M; Demanes DJ; Lamb J; Caprioli J; McCannel TA
J Glaucoma; 2020 Jan; 29(1):1-10. PubMed ID: 31688338
[TBL] [Abstract][Full Text] [Related]
10. [Iodine-125 brachytherapy and trans-scleral tumor resection in large uveal melanomas].
Bechrakis NE; Bornfeld N; Zöller I; Foerster MH
Ophthalmologe; 2001 Aug; 98(8):736-42. PubMed ID: 11552413
[TBL] [Abstract][Full Text] [Related]
11. Incidence and indications for pars plana vitrectomy following the treatment of posterior uveal melanomas in Scotland.
Chia SN; Smith HB; Hammer HM; Kemp EG
Eye (Lond); 2015 Jun; 29(6):748-56. PubMed ID: 25853443
[TBL] [Abstract][Full Text] [Related]
12. [Ciliary body melanomas. Survival and prognostic aspects after brachytherapy or proton therapy].
Gambrelle J; Kodjikian L; Rouberol F; Donate D; Duquesne N; Jean-Louis B; Chauvel P; Gérard JP; Romestaing P; Grange JD
J Fr Ophtalmol; 2004 Jan; 27(1):40-7. PubMed ID: 14968076
[TBL] [Abstract][Full Text] [Related]
13. [CyberKnife®: new treatment option for uveal melanoma].
Mor JM; Semrau R; Baus W; Koch KR; Schaub F; Cursiefen C; Marnitz S; Heindl LM
Ophthalmologe; 2018 Apr; 115(4):302-308. PubMed ID: 28849326
[TBL] [Abstract][Full Text] [Related]
14. Uveal Melanoma Treatment and Prognostication.
Dogrusöz M; Jager MJ; Damato B
Asia Pac J Ophthalmol (Phila); 2017; 6(2):186-196. PubMed ID: 28399342
[TBL] [Abstract][Full Text] [Related]
15. Sclerouvectomy plus intraoperative ophthalmic brachytherapy for iris-ciliary body melanomas.
Relimpio-López MI; Garrido-Hermosilla AM; Espejo-Arjona F; Coca-Gutiérrez LM; Díaz-Granda MJ; Rodríguez-de-la-Rúa-Franch E
Surg Oncol; 2021 Mar; 36():113-114. PubMed ID: 33340808
[TBL] [Abstract][Full Text] [Related]
16. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
[TBL] [Abstract][Full Text] [Related]
17. New treatment modalities for uveal melanoma.
De Potter P; Shields CL; Shields JA
Curr Opin Ophthalmol; 1996 Jun; 7(3):27-32. PubMed ID: 10163456
[TBL] [Abstract][Full Text] [Related]
18. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
19. Retrospective evaluation of patients with uveal melanoma treated by stereotactic radiosurgery with and without tumor resection.
Suesskind D; Scheiderbauer J; Buchgeister M; Partsch M; Budach W; Bartz-Schmidt KU; Ritz R; Grisanti S; Paulsen F
JAMA Ophthalmol; 2013 May; 131(5):630-7. PubMed ID: 23494018
[TBL] [Abstract][Full Text] [Related]
20. 23-mm iodine-125 plaque for uveal melanoma: benefit of vitrectomy and silicone oil on visual acuity.
McCannel TA; Kamrava M; Demanes J; Lamb J; Bartlett JD; Almanzor R; Chun M; McCannel CA
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2461-2467. PubMed ID: 27638702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
